Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Todd Neale

March 27, 2024

News Conference News AHA 2023

Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

Todd Neale

November 17, 2023

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Michael O'Riordan

October 26, 2017

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Industry News

FDA strengthens warning on NSAID labels

July 10, 2015

News Daily News

Mejor Respuesta al Clopidogrel a Mayores Niveles de Tabaquismo

Jason Kahn

March 21, 2012

News Daily News

Better Clopidogrel Response Seen with Increased Smoking Levels

Jason Kahn

March 21, 2012

Advertisement

Year in Review: Top Prevention Stories of 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

TCTMD’s Michael O’Riordan Wins Digital Health Award

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

TCTMD’s Top 10 Most Popular Stories for January 2018

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

FDA strengthens warning on NSAID labels

Mejor Respuesta al Clopidogrel a Mayores Niveles de Tabaquismo

Better Clopidogrel Response Seen with Increased Smoking Levels

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content